Terranet AB (publ) (“Terranet” or the “Company”) today announces the outcome of the exercise of warrants of series TO7. In total, 173,029,725 warrants of series TO7 were exercised, corresponding to approximately 95 percent of the total number...
Significant events during the first quarter – Successful prototype demo in lab conducted at the end of March During the first quarter of the year, product development focused on the prototype demonstration in a lab environment, which was carried out with...
Väsentliga händelser under första kvartalet – Framgångsrik prototypdemo i labb genomförd i slutet av mars Under årets första kvartal har produktutvecklingen fokuserat på genomförandet av prototypdemonstrationen i...
Terranet AB (publ) meddelar idag att bolaget i dagsläget inte avser att ytterligare investera holoride GmbH. Beslutet att inte bidra med mer kapital speglar Terranets strategi att prioritera och accelerera den egna utvecklingen av BlincVision. Terranet...
Terranet AB (publ) today announces that the company does not intend to further invest in holoride GmbH at this time. The decision not to contribute with more capital reflects Terranet’s strategy to prioritize and accelerate its own development of BlincVision....
Recent Comments